Journal of Cholesterol and Heart Disease

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

About The Journal Open Access

Journal of Cholesterol and Heart Disease

The cholesterol molecule is a combination of fat and protein that is found in the blood stream. Different permutations of protein and fat make the molecule either healthy or harmful. The liver produces cholesterol and sends it to other parts of the body for the production of hormones and cell membranes. When cholesterol is transported in the bloodstream, it is packed into low-density lipoproteins (LDL), sometimes called the “bad cholesterol.” Although LDL is needed in limited quantities (LDL delivers cholesterol to various parts of the body), a high LDL cholesterol level can dramatically increase risk of a heart attack.

Abnormal levels of cholesterol can lead to cardiovascular disease. High blood cholesterol is generally the reason for most of the cardiovascular disease, as it accumulate in the arteries and narrow it, a condition called Atherosclerosis.

You may submit manuscripts as an email attachment to [email protected] or you may submit manuscripts online at https://www.scholarscentral.org/submissions/cholesterol-heart-disease.html

Fast Editorial Execution and Review Process (FEE-Review Process):

Journal of cholesterol and heart disease is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

H-index

Articles published in Journal of Cholesterol and Heart Disease have been cited by esteemed scholars and scientists all around the world. Journal of Cholesterol and Heart Disease has got H-index 2 , which means every article in Journal of Cholesterol and Heart Disease has got 2 average citations.

Please submit your manuscript to
[email protected]

Just Published Articles View More

Opinion Article December 28, 2022

P.1-2

J Cholest Heart Dis: 6(6): 1-2

Utilization of naturopathy and primary care.

Amie Alastair

DOI:

Short Communication December 28, 2022

P.1-2

J Cholest Heart Dis: 6(6): 1-2

Hypertension: a detailed study.

Alexander Jonah

DOI:

Mini Review December 28, 2022

P.1-2

J Cholest Heart Dis: 6(6): 1-2

Detection of obesity, risk factors associated with obesity on coronary heart disease.

Yannis Li

DOI:

Perspective December 28, 2022

P.1-2

J Cholest Heart Dis: 6(6): 1-2

Roles and therapeutic techniques in atherosclerosis.

Lemin Zhu

DOI:

Rapid Communication December 28, 2022

P.1-2

J Cholest Heart Dis: 6(6): 1-2

Changing perspectives from the present and the future about the pathogenesis of hypertrophic cardiomyopathy.

Cetin Etsuko

DOI:

Perspective December 01, 2022

P.1-2

J Cholest Heart Dis: 6(5): 1-2

Targeting genetic architecture in diagnosis and management of hypertrophic cardiomyopathy.

Ana Morales

Relevant Topics

Get the App

Vizag Tech Summit